Press Releases

Indivior to Participate in Upcoming Healthcare Events During National Recovery Month

Richmond, VA, September 14, 2021 - Indivior PLC, (LON: INDV) Indivior PLC, (LON: INDV) today announced that the Company’s leadership will participate in two upcoming virtual events as part of our ongoing effort to raise awareness about the opioid crisis and to address barriers to evidence-based treatment, including unequal access to addiction treatment and support in the U.S.

  • Financial Times: The Future of American Healthcare
    Tuesday, September 14th at 1:55 p.m. – 2:35 p.m. EDT
    Indivior CEO Mark Crossley will participate in a panel discussion entitled “Mental health in a nation transformed by crisis” and share remarks about the impact of COVID-19 on opioid use disorder and how innovative policy and treatment options can better address the opioid epidemic. Registration to attend the event is available here.
  • The Hill: Advancing Health Equity in Our Nation’s Opioid Response
    Tuesday, September 21st at 1:00 p.m. EDT
    Indivior Chief Scientific Officer Christian Heidbreder will share remarks during a panel discussion about disparities in addiction treatment among vulnerable populations. Registration to attend the event is available here

September is National Recovery Month, a national observance to draw special attention to people struggling with substance use disorders and mental illnesses.

About Indivior

Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 700 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit to learn more. Connect with Indivior on LinkedIn by visiting


Media Contacts:

+1 804-594-0836

Tulchan Communications
+44 207-353-4200

Investor Contact:

Jason Thompson
Vice President, Investor Relations
Indivior PLC (LON: INDV)
Mobile: 804-402-7123

A pdf version of this press release can be downloaded here.